ARVN RSI Chart
Last 7 days
-0.4%
Last 30 days
-14.0%
Last 90 days
-33.0%
Trailing 12 Months
33.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 137.3M | 158.1M | 159.4M | 78.5M |
2022 | 74.5M | 102.8M | 126.8M | 131.3M |
2021 | 25.2M | 24.9M | 26.6M | 53.5M |
2020 | 45.2M | 46.9M | 24.5M | 25.9M |
2019 | 14.2M | 14.8M | 41.5M | 43.0M |
2018 | 10.0M | 11.7M | 13.5M | 14.3M |
2017 | 0 | 0 | 0 | 7.6M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 18, 2024 | berkowitz noah | acquired | - | - | 63,452 | chief medical officer |
Feb 23, 2024 | peck ronald | acquired | - | - | 39,250 | chief medical officer |
Feb 23, 2024 | houston john g | acquired | - | - | 124,450 | president and ceo |
Feb 23, 2024 | houston john g | sold | -244,472 | 47.05 | -5,196 | president and ceo |
Feb 23, 2024 | taylor ian | sold | -80,032 | 47.05 | -1,701 | chief scientific officer |
Feb 23, 2024 | cassidy sean a | sold | -80,079 | 47.05 | -1,702 | chief financial officer |
Feb 23, 2024 | taylor ian | acquired | - | - | 39,250 | chief scientific officer |
Feb 23, 2024 | loomis david k | acquired | - | - | 5,750 | chief accounting officer |
Feb 23, 2024 | peck ronald | sold | -79,938 | 47.05 | -1,699 | chief medical officer |
Jan 04, 2024 | taylor ian | acquired | 132,032 | 16.00 | 8,252 | chief scientific officer |
Which funds bought or sold ARVN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -0.26 | - | 833,000 | -% |
May 07, 2024 | M&T Bank Corp | reduced | -17.15 | -133,891 | 655,041 | -% |
May 07, 2024 | Concurrent Investment Advisors, LLC | sold off | -100 | -361,015 | - | -% |
May 07, 2024 | SEI INVESTMENTS CO | added | 219 | 695,756 | 1,011,660 | -% |
May 07, 2024 | Bank Pictet & Cie (Europe) AG | reduced | -4.79 | -13,145 | 277,980 | 0.01% |
May 07, 2024 | Arizona State Retirement System | added | 24.99 | 132,631 | 655,733 | -% |
May 07, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -76.31 | -835,491 | 260,394 | -% |
May 07, 2024 | Swiss National Bank | added | 27.49 | 1,026,230 | 4,710,050 | -% |
May 07, 2024 | Headlands Technologies LLC | sold off | -100 | -98,290 | - | -% |
May 07, 2024 | PANAGORA ASSET MANAGEMENT INC | added | 786 | 5,974,720 | 6,732,360 | 0.04% |
Unveiling Arvinas Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Arvinas Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 46.7B | 6.8B | -7.83 | 6.82 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.3B | 2.0B | -58.01 | 9.62 | ||||
BMRN | 15.5B | 2.5B | 75.6 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.2B | 107.9M | -9.48 | 48.09 | ||||
APLS | 5.1B | 524.1M | -12.3 | 9.79 | ||||
AXSM | 3.6B | 251.0M | -12.15 | 14.35 | ||||
ARWR | 3.1B | 240.7M | -10.53 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -45.95 | 3.88 | ||||
SMALL-CAP | ||||||||
CPRX | 1.7B | 411.3M | 26.68 | 4.22 | ||||
NVAX | 625.6M | 983.7M | -1.15 | 0.64 | ||||
CRBP | 451.6M | 881.7K | -13.38 | 481.06 | ||||
INO | 257.1M | 4.9M | -1.9 | 52.83 | ||||
IBIO | 6.6M | 2.1M | -0.24 | 2.14 |
Arvinas Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -15.5% | 25,300,000 | 29,950,000 | 34,600,000 | 54,500,000 | 32,500,000 | 37,850,000 | 33,200,000 | 33,800,000 | 26,500,000 | 33,250,000 | 9,300,000 | 5,500,000 | 5,500,000 | 6,315,915 | 7,596,776 | 5,747,681 | 6,239,628 | 4,893,273 | 30,050,227 | 4,016,489 | 4,016,489 |
Operating Expenses | -11.1% | 108,600,000 | 122,200,000 | 108,500,000 | 129,100,000 | 120,200,000 | 113,350,000 | 97,500,000 | 99,600,000 | 84,200,000 | 80,750,000 | 56,600,000 | 57,400,000 | 47,200,000 | 45,471,902 | 39,344,843 | 32,231,564 | 29,651,691 | 27,683,173 | 24,545,414 | 22,441,417 | 19,830,988 |
S&GA Expenses | -100.0% | - | 27,050,000 | 22,600,000 | 25,700,000 | 24,900,000 | 15,100,000 | 20,000,000 | 24,300,000 | 20,200,000 | 18,850,000 | 16,000,000 | 14,400,000 | 12,300,000 | 12,227,596 | 9,331,925 | 8,815,474 | 7,925,005 | 7,268,390 | 7,957,364 | 6,440,779 | 5,640,629 |
R&D Expenses | -11.4% | 84,300,000 | 95,150,000 | 85,900,000 | 103,400,000 | 95,300,000 | 98,250,000 | 77,500,000 | 75,300,000 | 64,000,000 | 61,900,000 | 40,600,000 | 43,000,000 | 34,900,000 | 33,244,306 | 30,012,918 | 23,416,090 | 21,726,686 | 20,414,783 | 16,588,050 | 16,000,638 | 14,190,359 |
EBITDA Margin | 3.3% | -4.42 | -4.57 | -1.73 | -1.72 | -1.97 | -1.86 | -1.36 | -1.72 | -2.39 | -3.35 | -4.11 | -4.41 | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | -6,350,000 | 3,400,000 | 1,800,000 | 1,200,000 | -1,100,000 | 300,000 | 400,000 | 500,000 | 51,250 | 16,250 | 16,250 | 16,250 | 16,250 | 22,903 | 22,778 | 23,638 |
Income Taxes | -93.7% | 100,000 | 1,600,000 | - | -300,000 | -400,000 | 10,800,000 | 2,200,000 | 3,400,000 | 4,500,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 54.8% | -69,300,000 | -153,200,000 | -63,900,000 | -65,600,000 | -81,200,000 | -69,250,000 | -61,100,000 | -64,100,000 | -56,600,000 | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | 3.3% | -4.48 | -4.64 | -1.76 | -1.75 | -2.01 | -1.91 | -1.45 | -1.79 | -2.47 | -3.44 | -4.33 | -4.62 | - | - | - | - | - | - | - | - | - |
Net Income | 55.2% | -69,400,000 | -154,800,000 | -64,000,000 | -66,600,000 | -81,900,000 | -82,900,000 | -66,200,000 | -70,000,000 | -63,400,000 | -52,950,000 | -46,800,000 | -50,300,000 | -41,000,000 | -41,514,424 | -30,819,866 | -25,226,539 | -21,739,171 | -21,047,716 | -17,675,373 | -17,164,646 | -14,404,492 |
Net Income Margin | 3.4% | -4.52 | -4.68 | -1.85 | -1.88 | -2.19 | -2.15 | -1.99 | -2.27 | -2.86 | -3.57 | -6.75 | -6.57 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -17.3% | -97,600,000 | -83,200,000 | -85,900,000 | -89,300,000 | -92,300,000 | -72,300,000 | -68,800,000 | -80,000,000 | -59,200,000 | -37,600,000 | 680,200,000 | -47,900,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -7.1% | 1,213 | 1,305 | 1,058 | 1,084 | 1,176 | 1,269 | 1,335 | 1,407 | 1,488 | 1,582 | 1,605 | 644 | 682 | 717 | 272 | 263 | 282 | 302 | 209 | 172 | 187 |
Current Assets | -7.0% | 1,190 | 1,280 | 1,033 | 1,057 | 1,148 | 1,240 | 1,305 | 1,376 | 1,457 | 1,553 | 1,576 | 628 | 665 | 703 | 258 | 250 | 270 | 291 | 200 | 163 | 180 |
Cash Equivalents | -70.0% | 94.00 | 312 | 114 | 91.00 | 130 | 81.00 | 133 | 93.00 | 62.00 | 108 | 260 | 53.00 | 346 | 588 | 89.00 | 22.00 | 36.00 | 9.00 | 12.00 | 11.00 | 29.00 |
Net PPE | -9.6% | 10.00 | 12.00 | 13.00 | 13.00 | 13.00 | 13.00 | 14.00 | 14.00 | 13.00 | 13.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 11.00 | 10.00 | 8.00 | 7.00 | 6.00 | 4.00 |
Liabilities | -6.5% | 603 | 645 | 601 | 620 | 665 | 704 | 713 | 736 | 765 | 800 | 787 | 61.00 | 66.00 | 75.00 | 67.00 | 65.00 | 71.00 | 75.00 | 75.00 | 56.00 | 59.00 |
Current Liabilities | -6.3% | 241 | 257 | 317 | 307 | 283 | 295 | 245 | 238 | 238 | 262 | 183 | 42.00 | 40.00 | 49.00 | 40.00 | 34.00 | 33.00 | 33.00 | 29.00 | 21.00 | 21.00 |
Long Term Debt | -12.5% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
LT Debt, Current | 0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 |
LT Debt, Non Current | -100.0% | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Shareholder's Equity | -7.6% | 610 | 660 | 457 | 464 | 511 | 565 | 622 | 671 | 723 | 782 | 818 | 583 | 615 | 642 | 205 | 198 | 212 | 227 | 134 | 117 | 128 |
Retained Earnings | -5.2% | -1,402 | -1,332 | -1,177 | -1,113 | -1,047 | -965 | -882 | -816 | -746 | -682 | -629 | -583 | -532 | -491 | -450 | -419 | -394 | -372 | -351 | -333 | -316 |
Additional Paid-In Capital | 1.0% | 2,016 | 1,996 | 1,644 | 1,590 | 1,571 | 1,549 | 1,529 | 1,509 | 1,488 | 1,469 | 1,448 | 1,167 | 1,148 | 1,134 | 654 | 616 | 607 | 599 | 485 | 450 | 444 |
Shares Outstanding | 0.4% | 68.00 | 68.00 | 55.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 50.00 | 50.00 | 49.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 1,293 | - | - | - | 2,176 | - | - | - | 3,457 | - | - | - | 1,348 | - | - | - | 465 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -17.3% | -97,500 | -83,100 | -84,800 | -88,700 | -91,200 | -71,200 | -66,600 | -78,600 | -57,100 | -35,700 | 681,500 | -47,400 | -39,000 | -28,964 | -22,383 | -21,401 | -16,949 | -16,152 | 1,854 | -13,569 | -12,732 |
Share Based Compensation | 11.4% | 18,600 | 16,700 | 16,700 | 18,300 | 19,900 | 20,100 | 18,800 | 20,000 | 16,600 | 17,000 | 15,200 | 14,600 | 10,300 | 8,078 | 8,247 | 7,755 | 6,120 | 5,009 | 4,601 | 5,313 | 5,177 |
Cashflow From Investing | -138.0% | -127,800 | -53,700 | 70,000 | 48,600 | 138,600 | 19,400 | 105,800 | 109,000 | 8,600 | -115,600 | -741,100 | -249,100 | -207,800 | 56,912 | 59,283 | 5,610 | 42,495 | -95,431 | -31,814 | -4,228 | 38,374 |
Cashflow From Financing | -99.5% | 1,600 | 334,800 | 37,900 | 500 | 1,500 | 500 | 1,200 | 500 | 2,500 | 3,900 | 266,600 | 3,600 | 4,500 | 471,475 | 30,496 | 1,279 | 1,350 | 108,638 | 30,754 | 353 | -45.54 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 25.3 | $ 32.5 |
Operating expenses: | ||
Research and development | 84.3 | 95.3 |
General and administrative | 24.3 | 24.9 |
Total operating expenses | 108.6 | 120.2 |
Loss from operations | (83.3) | (87.7) |
Other income (expense) | ||
Other expense, net | 0.0 | (1.1) |
Interest income, net | 14.0 | 7.6 |
Total other income | 14.0 | 6.5 |
Net loss before income taxes and loss from equity method investment | (69.3) | (81.2) |
Income tax (expense) benefit | (0.1) | 0.4 |
Loss from equity method investment | 0.0 | (1.1) |
Net loss | $ (69.4) | $ (81.9) |
Net loss per common share, basic (in dollars per share) | $ (0.97) | $ (1.54) |
Net loss per common share, diluted (in dollars per share) | $ (0.97) | $ (1.54) |
Weighted average common shares outstanding, basic (in shares) | 71.7 | 53.3 |
Weighted average common shares outstanding, diluted (in shares) | 71.7 | 53.3 |
Statement of Comprehensive Income [Abstract] | ||
Net loss | $ (69.4) | $ (81.9) |
Other comprehensive loss: | ||
Unrealized (loss) gain on available-for-sale securities | (1.3) | 6.6 |
Comprehensive loss | $ (70.7) | $ (75.3) |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 88.0 | $ 311.7 |
Restricted cash | 5.5 | 5.5 |
Marketable securities | 1,081.3 | 949.3 |
Other receivables | 7.1 | 7.2 |
Prepaid expenses and other current assets | 8.4 | 6.5 |
Total current assets | 1,190.3 | 1,280.2 |
Property, equipment and leasehold improvements, net | 10.4 | 11.5 |
Operating lease right of use assets | 2.0 | 2.5 |
Collaboration contract asset and other assets | 9.9 | 10.4 |
Total assets | 1,212.6 | 1,304.6 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 76.4 | 92.2 |
Deferred revenue | 162.9 | 163.0 |
Current portion of operating lease liabilities | 1.5 | 1.9 |
Total current liabilities | 240.8 | 257.1 |
Deferred revenue | 361.0 | 386.2 |
Long term debt | 0.7 | 0.8 |
Operating lease liabilities | 0.4 | 0.5 |
Total liabilities | 602.9 | 644.6 |
Commitments and Contingencies (Note 13) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value, zero shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 0.0 | 0.0 |
Common stock, $0.001 par value; 68.3 and 68.0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 0.1 | 0.1 |
Accumulated deficit | (1,402.1) | (1,332.7) |
Additional paid-in capital | 2,016.1 | 1,995.7 |
Accumulated other comprehensive loss | (4.4) | (3.1) |
Total stockholders’ equity | 609.7 | 660.0 |
Total liabilities and stockholders’ equity | $ 1,212.6 | $ 1,304.6 |